Evidence map›Paper›PMID 22219371›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2012

Structural and mechanistic insight into N-glycan processing by endo-α-mannosidase.

Andrew J Thompson, Rohan J Williams, Zalihe Hakki, Dominic S Alonzi, Tom Wennekes, Tracey M Gloster, Kriangsak Songsrirote, Jane E Thomas-Oates, Tanja M Wrodnigg, Josef Spreitz and 4 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Sulfated and sialylatedThe Journal of biological chemistry · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 4 countries.

Andrew J ThompsonDepartment of Chemistry, University of York, Heslington, York YO10 5DD, United Kingdom.
Rohan J Williams
Zalihe Hakki
Dominic S Alonzi
Tom Wennekes
Tracey M Gloster
Kriangsak Songsrirote
Jane E Thomas-Oates
Tanja M Wrodnigg
Josef Spreitz
Arnold E Stütz
Terry D Butters
Spencer J Williams
Gideon J Davies
University of York · GBGraz University of Technology · ATUniversity of Melbourne · AUUniversity of Oxford · GBWageningen University & Research · NL

Funding

Biotechnology and Biological Sciences Research Council BB/G016127/1Wellcome Trust 095828
6 · The paper itself

Abstract

N-linked glycans play key roles in protein folding, stability, and function. Biosynthetic modification of N-linked glycans, within the endoplasmic reticulum, features sequential trimming and readornment steps. One unusual enzyme, endo-α-mannosidase, cleaves mannoside linkages internally within an N-linked glycan chain, short circuiting the classical N-glycan biosynthetic pathway. Here, using two bacterial orthologs, we present the first structural and mechanistic dissection of endo-α-mannosidase. Structures solved at resolutions 1.7-2.1 Å reveal a (β/α)(8) barrel fold in which the catalytic center is present in a long substrate-binding groove, consistent with cleavage within the N-glycan chain. Enzymatic cleavage of authentic Glc(1/3)Man(9)GlcNAc(2) yields Glc(1/3)-Man. Using the bespoke substrate α-Glc-1,3-α-Man fluoride, the enzyme was shown to act with retention of anomeric configuration. Complexes with the established endo-α-mannosidase inhibitor α-Glc-1,3-deoxymannonojirimycin and a newly developed inhibitor, α-Glc-1,3-isofagomine, and with the reducing-end product α-1,2-mannobiose structurally define the -2 to +2 subsites of the enzyme. These structural and mechanistic data provide a foundation upon which to develop new enzyme inhibitors targeting the hijacking of N-glycan synthesis in viral disease and cancer.

Indexed as

alpha-MannosidaseBacteroidesBiocatalysisCarbohydrate ConformationCatalytic DomainConserved SequenceHumansKineticsLigandsModels, MolecularPolysaccharidesSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationStatic Electricityalpha-MannosidaseLigandsPolysaccharides

Identifiers

PMID22219371
PMCPMC3271872
OpenAlexW2129553461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.